Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The National Stem Cell Centre, later renamed the Australian Stem Cell Centre (ASCC), was established in 2002 as Australia's first Biotechnology Centre of Excellence. Headquartered in Melbourne, the centre was a major strategic initiative funded by the Australian Government to position the country as a global leader in regenerative medicine. It operated as a collaborative research hub, bringing together scientists from various universities and institutes to develop stem cell-based therapies for conditions such as heart disease, diabetes, and neurological disorders. The organization focused on both embryonic and adult stem cell research, as well as the ethical and regulatory frameworks surrounding these technologies. Despite its significant role in the Australian biotech ecosystem, the centre ceased operations in 2011 after its federal funding was not renewed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Stem Cell Centre.